Paul Tudor Jones Zoetis Inc. Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Zoetis Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 342,815 shares of ZTS stock, worth $50.1 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

342,815

Previous 115,527 196.74%

Holding current value

$50.1 Million

Previous $19 Million 181.06%

% of portfolio

0.12%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$144.41 - $170.3 $32.8 Million - $38.7 Million	227,288 Added 196.74%	342,815 $53.5 Million
Q1 2025 May 15, 2025	SELL	$156.48 - $175.67 $5.97 Million - $6.7 Million	-38,121 Reduced 24.81%	115,527 $19 Million
Q4 2024 Feb 14, 2025	BUY	$162.24 - $194.42 $24.4 Million - $29.2 Million	150,430 Added 4674.64%	153,648 $25 Million
Q3 2024 Nov 14, 2024	SELL	$172.58 - $196.48 $11.2 Million - $12.7 Million	-64,812 Reduced 95.27%	3,218 $628,000
Q2 2024 Aug 14, 2024	SELL	$145.54 - $178.83 $42.3 Million - $52 Million	-290,732 Reduced 81.04%	68,030 $11.8 Million
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $55.9 Million - $67.5 Million	337,594 Added 1594.83%	358,762 $60.7 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $3.88 Million - $5.13 Million	-25,638 Reduced 54.78%	21,168 $4.18 Million
Q3 2023 Nov 15, 2023	SELL	$167.14 - $192.77 $3.62 Million - $4.18 Million	-21,674 Reduced 31.65%	46,806 $8.14 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $6.28 Million - $7.27 Million	39,027 Added 132.51%	68,480 $11.8 Million
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $9.72 Million - $11.7 Million	-66,802 Reduced 69.4%	29,453 $4.9 Million
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $7.65 Million - $9.18 Million	58,328 Added 153.79%	96,255 $14.1 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $5.4 Million - $6.65 Million	36,431 Added 2435.23%	37,927 $5.62 Million
Q2 2022 Aug 15, 2022	SELL	$155.97 - $200.09 $4.59 Million - $5.88 Million	-29,404 Reduced 95.16%	1,496 $257,000
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $1 Million - $1.3 Million	-5,537 Reduced 15.2%	30,900 $5.83 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $6.66 Million - $8.49 Million	34,374 Added 1666.21%	36,437 $8.89 Million
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $153,892 - $170,477	-813 Reduced 28.27%	2,063 $401,000
Q2 2021 Aug 16, 2021	BUY	$155.9 - $187.99 $448,368 - $540,659	2,876 New	2,876 $536,000
Q1 2021 May 17, 2021	SELL	$144.0 - $169.39 $7.33 Million - $8.62 Million	-50,885 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$157.07 - $174.35 $6.66 Million - $7.39 Million	42,396 Added 499.42%	50,885 $8.42 Million
Q3 2020 Nov 16, 2020	BUY	$137.1 - $165.37 $642,176 - $774,593	4,684 Added 123.1%	8,489 $1.4 Million
Q2 2020 Aug 14, 2020	BUY	$111.92 - $142.53 $79,127 - $100,768	707 Added 22.82%	3,805 $521,000
Q1 2020 May 15, 2020	BUY	$92.66 - $144.94 $287,060 - $449,024	3,098 New	3,098 $365,000
Q1 2019 May 15, 2019	SELL	$81.56 - $100.67 $1.12 Million - $1.38 Million	-13,673 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $2.67 Million - $3.21 Million	-33,723 Reduced 71.15%	13,673 $1.17 Million
Q3 2018 Nov 14, 2018	BUY	$83.5 - $93.23 $2.33 Million - $2.6 Million	27,865 Added 142.67%	47,396 $4.34 Million
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $1.14 Million - $1.27 Million	14,208 Added 266.92%	19,531 $1.66 Million
Q1 2018 May 15, 2018	BUY	$71.51 - $84.69 $380,647 - $450,804	5,323 New	5,323 $445,000
Q4 2017 Feb 14, 2018	SELL	$63.24 - $72.8 $1.08 Million - $1.24 Million	-17,010 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $1.02 Million - $1.11 Million	17,010	17,010 $1.09 Million

Others Institutions Holding ZTS

# of Institutions

2,118

Shares Held

430M

Call Options Held

1.47M

Put Options Held

1.45M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $68.4B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account